Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer.

N Engl J Med 2021 Jun 24

Acquired Resistance to KRAS^G12C Inhibition in Cancer.

Related Questions

Is there any role for re-biopsy and NGS for patients with NSCLC and KRAS G12C at time of progression after first line therapy before starting sotorasib, or after progression on sotorasib?

New comment by Medical Oncologist at CompHealth ( August 14, 2023)

Prefer liquid

Read more (1 Answer available)